Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 205

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 205
---
995 |     | $ | 321,017 |

Note 5. PROPERTY AND EQUIPMENT, NET

Property and equipment at December 31, 2024 and 2023, are summarized below:

SCHEDULE OF PROPERTY AND EQUIPMENT

|                                |     | December 
 31,      |     2024 |   |     |   |     2023 |   |
|:-------------------------------|:----|:---------|---------:|:--|:----|:--|---------:|:--|
| Lab equipment                  |     | $        |  662,747 |   |     | $ |  647,214 |   |
| Computers and software         |     |          |   81,433 |   |     |   |   68,682 |   |
| Leasehold improvements         |     |          |   19,353 |   |     |   |    9,941 |   |
| Vehicles                       |     |          |  148,103 |   |     |   |  105,919 |   |
| Property                       
 and equipment, gross           |     |          |  911,636 |   |     |   |  831,756 |   |
| Less: accumulated depreciation 
 and amortization               |     |          | (536,251 | ) |     |   | (373,123 | ) |
| Total                          
 property and equipment, net    |     | $        |  375,385 |   |     | $ |  458,633 |   |

Total property and equipment depreciation and amortization expense was $162,332 and $233,064 for the years ended December 31, 2024 and 2023, respectively.

Note 6. ACCRUED EXPENSES

Accrued expenses at December 31, 2024 and 2023, are summarized below:

SCHEDULE OF ACCRUED EXPENSES

|                        |     | December 
 31,      |      2024 |     |   |      2023 |
|:-----------------------|:----|:---------|----------:|:----|:--|----------:|
| Compensation           |     | $        | 1,079,839 |     | $ |   857,037 |
| Legal and professional |     |          |    98,477 |     |   |   257,926 |
| Clinical               |